Associated comorbidities in psoriasis and inflammatory bowel disease

A. M. Binus, Jiali Han, A. A. Qamar, E. A. Mody, E. W. Holt, A. A. Qureshi

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Background The association between psoriasis and inflammatory bowel disease (IBD) has been previously reported although a great deal remains unknown about associated comorbidities. Objectives The aim of this study was to examine comorbidities in individuals diagnosed with both psoriasis and IBD, and to compare those with individuals diagnosed with psoriasis-only. We also looked at differences within the IBD group by clearly defining that cohort. Methods We included 146 patients diagnosed with both psoriasis and IBD and 146 controls diagnosed of psoriasis-only without previous records of IBD, matched by gender, ethnicity and age (±5 years). Patients were obtained from the research patient data repository of Brigham and Women's Hospital (BWH) and Massachusetts General Hospital. Controls were obtained from the psoriatic arthritis and psoriasis follow-up study (PAFS) at BWH. The comparison between the two groups included socio-demographics, comorbidities and laboratory inflammation parameters. Results Compared to individuals with psoriasis-only, patients with both psoriasis and IBD had significantly higher rates of autoimmune thyroiditis (2.1% vs. 6.8%), hepatitis (0.7 vs. 6.2%) and diabetes (11.0% vs. 26.7%). In addition, of the 146 patients with psoriasis and IBD, 60 (41.1%) were diagnosed with seronegative arthritis. The average C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) of the last visits in our clinics were significantly elevated compared to the individuals with psoriasis-only (ESR, 33.5 vs. 4.0 mm/h; CRP, 9.1 vs. 2.3 mg/L; both P-values <0.0001). Conclusions We found that patients with both, psoriasis and IBD have a number of further associated comorbidities, some at significantly higher levels than individuals with psoriasis-only. Common inflammatory pathways and genetic predispositions for specific patterns in the immune response may play an important role in the evolution of associated conditions.

Original languageEnglish (US)
Pages (from-to)644-650
Number of pages7
JournalJournal of the European Academy of Dermatology and Venereology
Volume26
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Psoriasis
Comorbidity
Blood Sedimentation
C-Reactive Protein
Autoimmune Thyroiditis
Psoriatic Arthritis
Genetic Predisposition to Disease
General Hospitals
Hepatitis
Arthritis
Demography
Inflammation

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Associated comorbidities in psoriasis and inflammatory bowel disease. / Binus, A. M.; Han, Jiali; Qamar, A. A.; Mody, E. A.; Holt, E. W.; Qureshi, A. A.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 26, No. 5, 01.05.2012, p. 644-650.

Research output: Contribution to journalReview article

Binus, A. M. ; Han, Jiali ; Qamar, A. A. ; Mody, E. A. ; Holt, E. W. ; Qureshi, A. A. / Associated comorbidities in psoriasis and inflammatory bowel disease. In: Journal of the European Academy of Dermatology and Venereology. 2012 ; Vol. 26, No. 5. pp. 644-650.
@article{5a1bcdeb299841e69ed78d0bb343c11e,
title = "Associated comorbidities in psoriasis and inflammatory bowel disease",
abstract = "Background The association between psoriasis and inflammatory bowel disease (IBD) has been previously reported although a great deal remains unknown about associated comorbidities. Objectives The aim of this study was to examine comorbidities in individuals diagnosed with both psoriasis and IBD, and to compare those with individuals diagnosed with psoriasis-only. We also looked at differences within the IBD group by clearly defining that cohort. Methods We included 146 patients diagnosed with both psoriasis and IBD and 146 controls diagnosed of psoriasis-only without previous records of IBD, matched by gender, ethnicity and age (±5 years). Patients were obtained from the research patient data repository of Brigham and Women's Hospital (BWH) and Massachusetts General Hospital. Controls were obtained from the psoriatic arthritis and psoriasis follow-up study (PAFS) at BWH. The comparison between the two groups included socio-demographics, comorbidities and laboratory inflammation parameters. Results Compared to individuals with psoriasis-only, patients with both psoriasis and IBD had significantly higher rates of autoimmune thyroiditis (2.1{\%} vs. 6.8{\%}), hepatitis (0.7 vs. 6.2{\%}) and diabetes (11.0{\%} vs. 26.7{\%}). In addition, of the 146 patients with psoriasis and IBD, 60 (41.1{\%}) were diagnosed with seronegative arthritis. The average C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) of the last visits in our clinics were significantly elevated compared to the individuals with psoriasis-only (ESR, 33.5 vs. 4.0 mm/h; CRP, 9.1 vs. 2.3 mg/L; both P-values <0.0001). Conclusions We found that patients with both, psoriasis and IBD have a number of further associated comorbidities, some at significantly higher levels than individuals with psoriasis-only. Common inflammatory pathways and genetic predispositions for specific patterns in the immune response may play an important role in the evolution of associated conditions.",
author = "Binus, {A. M.} and Jiali Han and Qamar, {A. A.} and Mody, {E. A.} and Holt, {E. W.} and Qureshi, {A. A.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1111/j.1468-3083.2011.04153.x",
language = "English (US)",
volume = "26",
pages = "644--650",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Associated comorbidities in psoriasis and inflammatory bowel disease

AU - Binus, A. M.

AU - Han, Jiali

AU - Qamar, A. A.

AU - Mody, E. A.

AU - Holt, E. W.

AU - Qureshi, A. A.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Background The association between psoriasis and inflammatory bowel disease (IBD) has been previously reported although a great deal remains unknown about associated comorbidities. Objectives The aim of this study was to examine comorbidities in individuals diagnosed with both psoriasis and IBD, and to compare those with individuals diagnosed with psoriasis-only. We also looked at differences within the IBD group by clearly defining that cohort. Methods We included 146 patients diagnosed with both psoriasis and IBD and 146 controls diagnosed of psoriasis-only without previous records of IBD, matched by gender, ethnicity and age (±5 years). Patients were obtained from the research patient data repository of Brigham and Women's Hospital (BWH) and Massachusetts General Hospital. Controls were obtained from the psoriatic arthritis and psoriasis follow-up study (PAFS) at BWH. The comparison between the two groups included socio-demographics, comorbidities and laboratory inflammation parameters. Results Compared to individuals with psoriasis-only, patients with both psoriasis and IBD had significantly higher rates of autoimmune thyroiditis (2.1% vs. 6.8%), hepatitis (0.7 vs. 6.2%) and diabetes (11.0% vs. 26.7%). In addition, of the 146 patients with psoriasis and IBD, 60 (41.1%) were diagnosed with seronegative arthritis. The average C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) of the last visits in our clinics were significantly elevated compared to the individuals with psoriasis-only (ESR, 33.5 vs. 4.0 mm/h; CRP, 9.1 vs. 2.3 mg/L; both P-values <0.0001). Conclusions We found that patients with both, psoriasis and IBD have a number of further associated comorbidities, some at significantly higher levels than individuals with psoriasis-only. Common inflammatory pathways and genetic predispositions for specific patterns in the immune response may play an important role in the evolution of associated conditions.

AB - Background The association between psoriasis and inflammatory bowel disease (IBD) has been previously reported although a great deal remains unknown about associated comorbidities. Objectives The aim of this study was to examine comorbidities in individuals diagnosed with both psoriasis and IBD, and to compare those with individuals diagnosed with psoriasis-only. We also looked at differences within the IBD group by clearly defining that cohort. Methods We included 146 patients diagnosed with both psoriasis and IBD and 146 controls diagnosed of psoriasis-only without previous records of IBD, matched by gender, ethnicity and age (±5 years). Patients were obtained from the research patient data repository of Brigham and Women's Hospital (BWH) and Massachusetts General Hospital. Controls were obtained from the psoriatic arthritis and psoriasis follow-up study (PAFS) at BWH. The comparison between the two groups included socio-demographics, comorbidities and laboratory inflammation parameters. Results Compared to individuals with psoriasis-only, patients with both psoriasis and IBD had significantly higher rates of autoimmune thyroiditis (2.1% vs. 6.8%), hepatitis (0.7 vs. 6.2%) and diabetes (11.0% vs. 26.7%). In addition, of the 146 patients with psoriasis and IBD, 60 (41.1%) were diagnosed with seronegative arthritis. The average C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) of the last visits in our clinics were significantly elevated compared to the individuals with psoriasis-only (ESR, 33.5 vs. 4.0 mm/h; CRP, 9.1 vs. 2.3 mg/L; both P-values <0.0001). Conclusions We found that patients with both, psoriasis and IBD have a number of further associated comorbidities, some at significantly higher levels than individuals with psoriasis-only. Common inflammatory pathways and genetic predispositions for specific patterns in the immune response may play an important role in the evolution of associated conditions.

UR - http://www.scopus.com/inward/record.url?scp=84860221763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860221763&partnerID=8YFLogxK

U2 - 10.1111/j.1468-3083.2011.04153.x

DO - 10.1111/j.1468-3083.2011.04153.x

M3 - Review article

C2 - 21689167

AN - SCOPUS:84860221763

VL - 26

SP - 644

EP - 650

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 5

ER -